Navigation Links
Where did you get those eyes and that brain?
Date:11/15/2010

Philadelphia, PA, 15 November 2010 - A family history of Alzheimer's disease significantly increases the risk for developing this disorder, but a new study in Biological Psychiatry suggests that which of your parents has the disease is very important.

Alzheimer's is the most common form of dementia in late-life, affecting over 5 million elderly in the United States alone. In order to develop preventative treatments, it is necessary to identify those individuals who are at highest risk for developing Alzheimer's.

Although individuals with a parental history of Alzheimer's are at increased risk for developing the disease, the specific biological and genetic mechanisms accounting for this increased risk are not known.

An important consideration may be a phenomenon called genomic imprinting, where the pattern of the inherited disease differs based on whether the risk genes are inherited from the mother or the father. Imprinting is a type of epigenetic regulation, meaning that long lasting changes in gene function are produced through regulatory mechanisms rather than by altering the sequence of the DNA.

In this new study, researchers set out to evaluate Alzheimer's risk in healthy, cognitively normal individuals by measuring their cerebrospinal fluid proteins, which are known to be altered in Alzheimer's. They compared individuals with a maternal or paternal history of Alzheimer's to individuals with no family history.

Only individuals whose mothers had Alzheimer's showed altered levels of a protein called amyloid, a major hallmark of Alzheimer's pathology, as well as proteins involved with oxidative stress (i.e., free radicals, which are harmful to the brain as well as the rest of the body). In contrast, individuals whose fathers had Alzheimer's and those with no family history had protein levels within normal range.

"Our data indicate that adult children of mothers with Alzheimer's may be at increased
'/>"/>

Contact: Chris J. Pfister
C.Pfister@elsevier.com
215-239-3266
Elsevier
Source:Eurekalert

Page: 1 2

Related biology news :

1. A new journal where molecular biology meets clinical research
2. Where optics meets medicine
3. Survey highlights support for nanotech in health fields but disapproval elsewhere
4. Where theres wildfire smoke, theres toxicity
5. Where do the fattest Germans live?
6. Mama whales teach babies where to eat
7. When fish farms are built along the coast, where does the waste go?
8. Healthy food availability could depend on where you live -- so does the quality of your diet
9. UTSA plant biologists publish where their peers are -- on the Web
10. Retail Anywhere Adds U.are.U Biometrics From DigitalPersona to Flagship Point of Sale Solution
11. Where do puffins go in the winter?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... in pharmacies and health stores, phosphatidylserine is a ... soy. Proven to improve cognition and slow memory ... experiencing memory impairment. Now a team headed by ... Tel Aviv University,s Department of Human Molecular ... improves the functioning of genes involved in degenerative ...
(Date:5/21/2013)... gathering of biomass experts , Where? ... When? 03-07 June 2013 , ... resource assessment, market and policy developments, manufacturing and installation, ... and benefiting from its 2013 edition from a record ... 60 countries, more than 240 plenary and oral presentations, ...
(Date:5/20/2013)... 2013) University of Minnesota Medical School researchers from ... with the University,s Brain Tumor Program, have developed a ... (MPNST) that allow them to discover new genes and ... research was published this week in the journal ... method, researchers in the lab of David Largaespada, Ph.D., ...
Breaking Biology News(10 mins):Common food supplement fights degenerative brain disorders 221st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4U of M researchers develop model for better testing, targeting of MPNST 2
... chimpanzee mating preferences have found that although male ... older, not younger, females as mates. The findings ... that of humans, their primate cousins. The basis ... that whereas chimpanzees participate in a relatively promiscuous ...
... most common colds, struck two immunosuppressed lung transplant patients, ... The two were part of a group of 11 ... HRV in both the upper and lower airways, overturning ... tissue. , The research appears in the second issue ...
... led by scientists from the United States and New ... deep-sea communities living around methane seeps off New Zealand's ... cold seeps have been viewed and sampled in the ... of these intriguing ecosystems,' says Dr Amy Baco-Taylor, from ...
Cached Biology News:Male chimpanzees prefer mating with old females 2Common cold virus leads to death in lung transplant patients 2Extraordinary life found around deep-sea gas seeps 2Extraordinary life found around deep-sea gas seeps 3
(Date:5/21/2013)... 21, 2013 Smarter Security, Inc., provider ... today announced that Genzyme, a Sanofi company and leading ... Detective® CL for a multi-use facility in the United ... other Genzyme buildings, this latest order underscores the satisfaction ... tailgate detection device improving doorway access control. ...
(Date:5/21/2013)... FL (PRWEB) May 21, 2013 Many ... breakouts as contributor to acne. Recently physicians from ... of mental stress on the skin, and suggested using ... help reduce the chemicals produced from stress that cause ... from the negative feelings acne brings about, stress causes ...
(Date:5/21/2013)... 21, 2013  Synthetic Biologics, Inc. (NYSE MKT: SYN), a ... serious infectious diseases, announced today that Jeffrey Riley ... Annual Marcum LLP MicroCap Conference on Thursday, May 30, 2013 ... Grand Hyatt Hotel. Mr. Riley is scheduled to present at ... Synthetic Biologics, presentation can be accessed by logging onto the ...
(Date:5/21/2013)... Revolutionary Science, the manufacturer of the ... today that they have expanded their colony counter product ... IntelliCount, InCount and ImpressCount. These affordable colony counters ... in food microbiology and pharmaceutical manufacturing. , The previously ... A bright white enclosure with jet black accents represent ...
Breaking Biology Technology:Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions 2Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference 2Revolutionary Science Announces New Automatic and Manual Colony Counting Products 2
... Oct. 6 The ability of a proprietary elderberry ... a double-blind, placebo-controlled study, undertaken on behalf of HerbalScience ... by Dr. Fan-kun Kong, assisted by medical personnel at ... during the spring 2009 flu season and involved 64 ...
... Verenium Corporation (Nasdaq: VRNMD ), a pioneer in ... enzymes, today announced that it intends to offer, subject ... common stock, and potentially warrants, in an underwritten public ... 9:30 am EDT on Tuesday, October 6, 2009. Lazard ...
... LEUVEN, Belgium, October 5 , ... (ASRS),Conference in New York , ThromboGenics ... and development of innovative medicines for eye,disease, vascular disease and ... intravitreal injection for the treatment of,Diabetic Macular Edema (MIVI II ...
Cached Biology Technology:HerbalScience Releases Results of Pilot Clinical Study on Efficacy of Its Proprietary Elderberry Extract in Addressing Flu-Like Symptoms 2HerbalScience Releases Results of Pilot Clinical Study on Efficacy of Its Proprietary Elderberry Extract in Addressing Flu-Like Symptoms 3HerbalScience Releases Results of Pilot Clinical Study on Efficacy of Its Proprietary Elderberry Extract in Addressing Flu-Like Symptoms 4Verenium Announces Proposed Public Offering of Common Stock 2Verenium Announces Proposed Public Offering of Common Stock 3ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema (MIVI II DME) 2ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema (MIVI II DME) 3ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema (MIVI II DME) 4
...
RABBIT ANTI PORCINE CARBOXYPEPTIDASE B...
LabFax: Immunochemistry...
... Maker, 1. Modular system for large ... up to six lab-cast or precast ... with 18- or 24-cm Immobiline DryStrip ... gel cassettes.Innovative design simplifies loading and ...
Biology Products: